NEW YORK (GenomeWeb News) – BioMarker Strategies, a molecular diagnostics developer focused on tumor testing, has won a Small Business Innovation Research grant from the National Cancer Institute.

The Fast-Track SBIR grant gives the company an initial award of $254,000, a number that could increase by up to $2 million after the initial phase of the work is completed, the firm said.

The company plans to use the funds to "expedite production" of a prototype of its SnapPath live-tumor cell testing system, BioMarker Strategies CEO Karen Olson said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.